KS

Kapil Singhal

Active Director Director DIN 09299781
DIN 09299781 First appointment Aug 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Kapil Singhal

Data last updated:

Kapil Singhal is a Director at Brezza Biotech Private Limited (since 2021). The company operates in Chemicals. Brezza Biotech Private Limited reported revenue of ₹1.63 Cr (FY 2025).

DIN 09299781
Primary Designation Director
Industry Chemicals
First Appointment 31 Aug 2021
Oldest Company Age 5 yrs
Largest company Brezza Biotech Private Limited · ₹1.63 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Brezza Biotech Private Limited U24230RJ2021PTC076709
Director31 Aug 20212021₹1.63 Cr (FY 2025)Active

Board colleagues of Kapil Singhal

NameDINCompanyDesignation
Rajesh Sharma11317894Brezza Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Brezza Biotech Private Limited
Premium access

Shareholding and investment profile for Kapil Singhal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kapil Singhal

Kapil Singhal currently holds 1 directorship: Brezza Biotech Private Limited (Director, since 31 Aug 2021, revenue ₹1.63 Cr (FY 2025)).

Kapil Singhal was first appointed on 31 Aug 2021 as Director at Brezza Biotech Private Limited.

The current boards of Kapil Singhal's companies include Rajesh Sharma (Brezza Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available